SCOR SE Shares Jump 3.12% at Midday, Approaching Resistance at €30.90
On Tuesday midday, the shares of reinsurer SCOR SE saw a significant increase, rising 3.12% to €30.40. This increase brings the quarterly performance to over 14%. The rebound occurs in a context of a generalized recovery of European markets during the session.
Midday Trading Update
At midday, SCOR SE is trading at €30.40, up 3.12% from the previous close of €29.48. The stock has thus advanced 14.2% over three months and 19.12% over a year. This session is taking place in a supportive environment for European indices: the CAC 40 is up 2.16% during the session, while the DAX has gained 2.22% and the FTSE 100 has advanced 1.67%. The SBF 120, which includes the reinsurer, is up 2.19%. In Asia, the Nikkei 225 closed with a gain of 2.88% and the Hang Seng ended up 2.17%. This generalized rebound movement benefits SCOR, whose nearly zero beta (-0.07) usually indicates a low correlation with benchmark indices. However, the VIX, a measure of market volatility in the US, was still high at 29.49 points as of March 6, indicating a still elevated level of tension.
Technical Analysis
Technically, today's progress brings the stock close to its resistance threshold at €30.90. A sustained crossing of this level could pave the way for a new phase of appreciation, while a pullback would bring the price back towards the upper Bollinger band, calculated at €30.82, which acts as a vigilance zone. The 50-day moving average, currently at €28.57, remains well below the current price, confirming the bullish trend initiated in recent weeks. The 200-day moving average, positioned at €28.48, converges with the 50-day average, underscoring the solidity of the recent movement. The RSI, at 51, remains in the neutral zone, suggesting that the stock is not in an overbought situation despite the significant rise on the day. On the calendar side, the group's general assembly is scheduled for April 28, 2026, followed by the publication of the first quarter results on May 6. These deadlines could be the next catalysts for the Parisian reinsurer's stock.